C12N 2720/12033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2720/12033 (Use of viral protein as therapeutic agent other than vaccine) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 3
- Assignees
- 2
- Inventors
- 4
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Recombinant oncolytic viruses for treatment of metastatic cancers5 Aug 2025US 12,378,289 B2Entos Pharmaceuticals Inc.
- Engineered immunostimulatory bacterial strains and uses thereof18 Jun 2024US 12,012,600 B2Actym Therapeutics, Inc.
- Engineered immunostimulatory bacterial strains and uses thereof8 Feb 2022US 11,242,528 B2Actym Therapeutics, Inc.
- Engineered immunostimulatory bacterial strains and uses thereof14 Apr 2022US 2022/0112501 A1Actym Therapeutics, Inc.
- Recombinant oncolytic viruses for treatment of metastatic cancers23 Apr 2020US 2020/0123204 A1Entos Pharmaceuticals Inc.
- Engineered immunostimulatory bacterial strains and uses thereof5 Mar 2020US 2020/0071702 A1Actym Therapeutics, Inc.
Most cited
By later US patents